Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q1 2014 · 10-Q
Revenue$214.66K$214.66K+21.7% vs Q1 2013 Net Income-$1.64M-$1.64MN/M vs Q1 2013 EPS Diluted-$0.05-$0.05N/M vs Q1 2013 Gross Profit$134,900+20.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
Operating Cash Flow-$1,584,248N/M Free Cash Flowderived-$1,603,137— Margins · derivedGross margin62.8%−0.9 pt vs Q1 2013
Operating margin-768.2%+216.0 pt vs Q1 2013
Net margin-764.4%+136.9 pt vs Q1 2013
ended Mar 31, 2014 · filed May 9, 2014 · 39 d after period end